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Objective: Cancer is a leading cause of death worldwide. 
Likewise, in Pakistan, it is a major health problem, with 
an approximate increase each year. Cancer treatment, 
particularly chemotherapy, produces a detrimental effect 
on individuals’ well‑being. Since the past few years, quality 
of life (QOL) is considered as the primary goal of cancer 
treatment in patients’ survival. This study aimed to assess 
the QOL and its determinants in adult cancer patients 
undergoing chemotherapy treatment. Methods: An analytical 
cross‑sectional design was employed to achieve the study 
objectives, utilizing consecutive sampling technique. A total 
of 150 adult (>19 years) cancer patients were recruited 
from a Tertiary Care Hospital in Karachi, Pakistan. The data 
were collected using the Functional Assessment of Cancer 
Therapy‑General, a QOL questionnaire. Multiple linear 
regression was run to determine the effect of predictor 
variables, with a mean QOL score. Results: The overall mean 
score of QOL as 57.37. The domains of physical and emotional 
well‑being were mainly affected by the chemotherapy 
treatment. Variables such as no previous hospitalization and 
no significant changes in life events were positively associated 
with the QOL. On the other hand, being female, unemployed, 
chemotherapy side effects (>1 week), impaired socialization, 
and discrimination by family/relatives were negatively 
associated with the QOL. Conclusions: The study findings 
suggested an overall low QOL among adult cancer patients 
undergoing chemotherapy treatment. It is recognized as a 
stressful treatment, which adversely affects the QOL of cancer 
patients. Interventions should focus on both the physical and 
psychological issues and need to be addressed to improve the 
QOL of adult cancer patients.
Key words: Cancer, chemotherapy, emotional well‑being, 
physical well‑being, quality of life, social well‑being
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Introduction
Cancer is the second most common cause of  deaths 
worldwide.[1] About 8.2 million people died due to different 
cancers in 2012.[2] In Asia, the incident rate of  cancer is 
expected to increase from 6.1 to 10.7 million in 2030, with an 
estimated increase in mortality rate from 4.1 to 7.5 million 
in 2030.[3] Likewise, the rate of  cancer is escalating in 
Pakistan; in 2012, of  its 173 million people, 1.4 million 
were reported as cases of  cancer, with an expected rise in 
the incident rate of  150,000 cases each year.[4]
Cancer affects a person’s quality of  life (QOL) in all 
domains. The impairment in the QOL starts from the 
diagnosis of  cancer and continues with the aggressive nature 
of  treatment. Chemotherapy is one of  the most common 
treatment modalities that patients receive to combat cancer. 
Among 65% of the cancer population, 25% patients receive 
chemotherapy as the first line of  treatment.[5] Chemotherapy 
is used to treat cancers by killing the rapidly growing abnormal 
cells and is believed to lower the recurrence of  cancer and 
increase the survival rate of patients.[6] However, besides these 
therapeutic effects, it also has serious adverse effects which 
can have detrimental effects on the QOL of an individual. 
Moreover, chemotherapy treatment is administered for a long 
time duration to get the desired effect and requires frequent 
hospitalization for disease management, which poses an 
additional burden on cancer patients.[7]
Unlike other therapies, chemotherapy exhibits several 
systemic side effects that are difficult to tolerate. The 
most commonly reported side effects experienced by 
patients during and after chemotherapy cycles include 
nausea/vomiting, thrombocytopenia, mouth ulcers, and 
fatigue.[8‑11] These adverse effects affect a person’s ability to 
work and decrease their functional capacity. The symptoms 
are not limited to physical dysfunction only, but they 
also interfere with patients’ psychological and emotional 
stability. An investigation conducted on female cancer 
patients showed that all the women who were working 
at the beginning of  the chemotherapy treatment left their 
employments gradually with increase in the cycles due to 
the discouraging attitude of  the employers.[12] Consequently, 
the individuals felt isolated, financially dependent on 
their families, and eventually, they lost interest in their 
life. Altered body image, that is, alopecia, an extremely 
distressing symptom, prevents people from going out for 
socialization and limits their normal life enjoyments.[13] 
In addition, the financial implication associated with the 
treatment is an added burden, which eventually affects the 
overall functioning of  an individual.[14] Thus, chemotherapy 
treatment produces an enormous physical, psychological, 
and emotional trauma among cancer patients, influencing 
their overall QOL.
The effects of chemotherapy may vary among individuals 
based on several factors, such as age, gender, cancer site, 
and stage of  the disease. The findings of  an American study 
indicated that older adults (65 and older) demonstrated 
better coping and QOL scores in comparison with young 
adult cancer patients.[15]
In a cross‑sectional study, it was found that being a female 
was significantly (P = 0.009) associated with psychological 
stress as compared to male gender.[16] Different cancer sites 
also adversely affect the QOL. A research study reported 
significant higher distress levels (P ≤	0.001)	in	breast	and	
digestive tract cancer patients as compared to those suffering 
from other cancer sites.[17] In addition to this, disease stage 
is also found to be a predictor of  QOL. A cross‑sectional 
investigation was carried out among cervical cancer patients 
revealed a significant decline in all QOL domains in women 
having Stage IV tumors.[18] Moreover, support from family 
and health‑care workers (HCWs) reported to have better 
QOL outcomes in cancer patients.[19,20]
Many of  the recent cancer studies focus on the physical 
and psychological adverse effects of  chemotherapy 
treatment or emphasize on certain specific cancer sites. 
However, studies examine the overall QOL components 
and its related factors are rare. Thus, this current study 
aimed to assess the QOL and its determinants in adult 
patients suffering from any type of  cancer and undergoing 
chemotherapy treatment. The study aimed to answer the 
following questions:
1. What is the QOL of  adult cancer patients undergoing 
chemotherapy treatment?
2. What are the determinants associated with the QOL 
of  adult cancer patients undergoing chemotherapy 
treatment?
Methods
An analytical cross‑sectional study design was used to 
answer the research questions.
Participants were recruited using consecutive sampling 
strategy from the Oncology Daycare Chemotherapy Unit 
of  a Tertiary Care Hospital in Karachi, Pakistan. This 
chemotherapy bay caters multiple patients daily for the 
administration of  different chemotherapeutic regimens. The 
patients who are admitted belong to different socioeconomic 
strata, ethnic background, and education level. Thus, it 
provides an opportunity to recruit population with diverse 
characteristics. Eligible participants were approached 
with the help of  patient schedule list and patients’ bedside 
nurses taking care of  these patients. Researcher recruited 
the willing patients after explaining them the research 
purpose, procedure, and potential risks and benefits of  
the study. Participants were selected on the following 
[Downloaded free from http://www.apjon.org on Saturday, May 13, 2017, IP: 111.68.111.34]
Chagani, et al.: Quality of Life in Adult Cancer Patients
Asia‑Pacific Journal of Oncology Nursing • Volume 4 • Issue 2 • April‑June 2017142
criteria: (a) patients aged 19 years and older, irrespective 
of  the site of  cancer, (b) patients who had received two 
or more cycles of  chemotherapy as these patients can 
explicitly tell how chemotherapy affect their life in terms of  
symptoms, financial burden, societal reaction in relation to 
their disease, and many others, and (c) patients who could 
speak and understand Urdu or English language. Patients 
who were known cases of  (a) diabetes, (b) heart disease, 
or (c) psychiatric illness, (d) not aware of  their diagnosis, 
and (e) not willing to participate were excluded from the 
research study.
Among 200 cancer patients approached, only 150 patients 
were agreed to participate in the study. All the agreed 
individuals completed the study questionnaire. All recruited 
individuals were provided a written informed consent 
before starting the process. The study was approved by 
the Institutional Ethical Review Board of  the Aga Khan 
University, Karachi, Pakistan.
A self‑developed questionnaire was used to collect data 
regarding the sociodemographic and clinical characteristics 
of  the study participants. This questionnaire was based on 
the information extracted from the existing literature. It 
has five main components inquiring personal and financial 
information, chemotherapy treatment and its related side 
effects, support system and level of  socialization during 
treatment. This questionnaire was applied through the 
interview.
The tool  Funct ional  Assessment  of  Cancer 
Therapy‑General was used to measure the QOL of  the 
study participants. This tool was developed by a group, 
the Functional Assessment of  Chronic Illness Therapy 
(FACIT) measurement system to measure the QOL of  
all types of  cancer patients. It consists of  27 questions 
measured on a 5‑point Likert scale (0 = not at all, 1 = a 
little bit, 2 = somewhat, 3 = quite a bit, 4 = very much). 
The tool comprises four common QOL domains: physical, 
social/family, emotional, and functional well‑being. The 
higher the score, the better the QOL. The original tool 
is in English and its translation is also available in Urdu 
language. Permission was obtained from the administration 
of  the FACIT system to use the tool.
The content validity index for the tool was 0.84 for 
both relevance and clarity. The value of  the reliability 
coefficient (Cronbach’s alpha) for the total scale was found 
to be 0.88, and for the subscales, it was ranged from 0.86 
to 0.70, respectively.
For the purpose of  data analysis, statistical package 
for social sciences (SPSS) version 19 was used. Mean and 
standard deviation (SD) were calculated for normally 
distributed continuous variables. For categorical variables, 
frequencies and proportions were reported. Multiple 
linear regression analysis was done to identify the factors 
associated with QOL of  adult cancer patients undergoing 
chemotherapy treatment.
Results
Demographic and disease‑related characteristics
Overall, 150 adult cancer patients participated in this 
study. Sixty‑six percent of  the participants were females. 
The mean age of  the study participants was 48.23 years. In 
relation with the occupational status, 74.0% of  the study 
participants were unemployed, and more than half  of  the 
participants (76.0%) had a single earning member in their 
families. Majority (60.7%) of  the study participants or 
families belonged to lower middle‑income group [Table 1]. 
28.7% were breast cancer patients, followed by 19.3% with 
ovarian tumors; whereas, the remaining participants were 
Table 1: Demographic profile of the adult cancer patients
Characteristics n=150 (%)
Gender
Male 51 (34.0)
Female 99 (66.0)
Age (years)
19-35 30 (20.0)
36-50 52 (34.7)
51-65 56 (37.3)
>65 12 (8.0)
Marital status
Married 124 (82.7)
Unmarried 24 (16.0)
Separated/divorced/widowed 2 (1.3)
Educational status
Below primary 10 (6.7)
Primary 11 (7.3)
Matric 18 (12.0)
Intermediate 30 (30.0)
Graduation and above 81 (54.0)
Occupational status
Employed 39 (26.0)
Unemployed 111 (74.0)
Earning members
1 114 (76.0)
2 28 (18.7)
>2 7 (4.70)
Monthly income
>20,000 11 (7.3)
21,000-50,000 91 (60.7)
51,000-100,000 41 (27.3)
>100,000 6 (4.0)
Financing of chemotherapy cost
Self-financed 124 (82.7)
Sponsored 19 (12.7)
Donors 7 (4.7)
Values are n (%)
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diagnosed with other cancer sites. Study participants were 
receiving palliative (42.0%), adjuvant (31.3%), and (26.7%) 
neo‑adjuvant chemotherapy treatment. With regard to 
side effects, most of  the patients (42.0%) experienced 
chemotherapy‑related symptoms, approximately for one 
week; however, for the management of  these side effects, a 
few were hospitalized. Majority (89.0%) of  the participants 
responded that they had received chemotherapy‑related 
education before the initiation of  the treatment [Table 2].
Quality of life and chemotherapy treatment
The overall QOL mean score was 57.37, with an 
SD of  +13.11. With respect to individual domains, the 
participants scored best in social/family well‑being with 
a mean of  22.33 (SD +3.42) whereas individuals had 
lower scores on emotional and physical well‑being, that is, 
10.32 (SD +4.95) and 10.41 (SD +5.32), respectively. The 
last domain, i.e., functional well‑being, presented a mean 
of  14.31 (SD +4.22) [Table 3].
Determinants of quality of life
The statistical significance of  the predictors with mean 
QOL was checked out through multiple linear regression 
analysis. The final model indicates that 34.1% of  the 
variability in the mean QOL is explained by female gender 
(β = −1.51, P = 0.012), unemployment (β = −1.34, P = 0.032), 
parents as caretaker of  the patients (β = −1.62, P = 0.03), 
and post‑chemotherapy side effects more than a week 
(β = −1.186, P = 0.04), which were the factors that resulted 
in poor QOL of  cancer patients. Moreover, patients who 
were avoiding socialization (β = −2.25, P .20.001) due to 
the stigma and discriminatory attitude by family/relative 
(β = −8.53, P .50.001) also reported a decline in their 
QOL, whereas no hospitalization due to the chemotherapy 
side effects (β =1.43, P = 0.01) and no other significant 
changes in the life during the treatment phase (β =1.56, 
P = 0.01) were the determinants contributed to better 
QOL [Table 4]. With respect to the Pakistani culture, the 
determinants which mainly affect these patients’ QOL were 
being a female cancer patient, side effects of  chemotherapy 
medicines, and reluctant to socialize due to stigmatization.
Discussion
Our study estimated an average mean score of  QOL 
as 57.37 depicts poor QOL among adult cancer patients 
undergoing chemotherapy treatment. Compared with the 
other study conducted on gynecological cancer patients 
which reported a score of  62.1, this was considered as 
low QOL among patients undergoing chemotherapy 
treatment.[44]
Within all the constructs, emotional well‑being appeared 
to be the most affected in our study participants, with 
a score of  10.32. Consistent with the study carried out 
among Turkish cancer patients, a lower score of  9.07 was 
identified.[21] Similarly, a study carried out among breast 
cancer patients in Brazil also reported emotional well‑being 
as the most negatively affected dimension of  QOL.[45]
The findings of  this study showed that poor physical 
health is associated with lower QOL. Lack of  energy 
(that is fatigue) and nausea/vomiting were the most 
common side effects reported by the study participants. 
Concurrent with the previous studies, chemotherapy was 
Table 2: Clinical characteristics and therapeutics of adult 
cancer patient
Characteristics n=150 (%)
Cancer type
Breast 43 (28.7)
Ovarian 29 (19.3)
Colon/rectum 23 (15.3)
Head and neck 6 (4.0)
Others 49 (32.7)
Disease stage
I 1 (0.7)
II 17 (11.3)
III 63 (42.0)
IV 64 (42.7)
Type of chemotherapy
Neo-adjuvant 40 (26.7)
Adjuvant 47 (31.3)
Palliative 63 (42.0)
Number of chemotherapy sessions received
2-5 84 (56.0)
6-10 45 (30.0)
11-15 17 (11.3)
>15 4 (2.70)
Duration of postchemotherapy side effects
2-3 days 47 (31.3)
1 week 63 (42.0)
>1 week 40 (26.7)
Hospitalization
Yes 34 (22.7)
No 116 (77.3)
Information received
Yes 134 (89.3)
No 16 (10.7)
Values are n (%)
Table 3: Quality of life scores in all four domains of the 
functional assessment of cancer therapy‑general tool
Domains n Minimum Maximum Mean SD
Physical well-being 150 2 24 10.41 5.321
Social/family well-being 150 11 27 22.33 3.422
Emotional well-being 150 2 23 10.32 4.954
Functional well-being 150 5 25 14.31 4.227
Overall QOL 150 29 92 57.37 13.11
P=0.05 is significant, QOL: Quality of life, SD: Standard deviation
[Downloaded free from http://www.apjon.org on Saturday, May 13, 2017, IP: 111.68.111.34]
Chagani, et al.: Quality of Life in Adult Cancer Patients
Asia‑Pacific Journal of Oncology Nursing • Volume 4 • Issue 2 • April‑June 2017144
highly associated with severe fatigue and nausea among 
cancer patients which affected their ability for self  and 
family care.[11,22]
Similar to the existing literature, the current study also 
showed that the female gender was significantly associated 
with the poor QOL. Generally, females are identified 
with efficiency in household work and childbearing and 
rearing. Women adapt these behaviors happily as a cultural 
norm. Moreover, this perception is a bigger reality for the 
traditional Pakistani society. Disturbance in these practices, 
due to the disease and its treatment, will greatly influence 
their QOL.[23,24]
It is well‑recognized that patients who experienced 
economic hardships are at the higher risk for developing 
distress. Our study has found a negative significant 
association between the financial status and QOL. 
These results are consistent with some of  the previous 
investigations.[25‑28] This finding is not surprising because 
chemotherapy is a prolonged and expensive treatment 
which creates financial burden among the cancer patients. 
In the developing country like Pakistan, this is even worse 
as majority of  the population belonged to lower‑middle 
class families and had one earning member who solely 
responsible for all family expenditure.
This situation poses an additional financial burden, along 
with the usual household expenses, on cancer patients and 
their families.
Although it is apparent that cancer itself  affects the 
physical functioning of  a person, with the effects of  
chemotherapy treatment, it becomes worse. This study 
revealed that longer duration of  post chemotherapy side 
effects (more than a week) impacts negatively on the 
QOL; these findings were also in line with the existing 
literature.[29‑32] Several other researches indicate frequent 
hospitalization due to chemotherapy adverse effects.[33‑35] 
On the contrary, in the current study, although a majority 
of  the study participants faced severe side effects for a week 
or more, a few hospitalizations were reported by them. The 
low number of  hospitalization in the present study could be 
explained by the findings that the majority of  the patients 
were educated by the HCWs about the management of  
chemotherapy side effects, before starting the actual therapy. 
This received knowledge may have facilitated them in 
handling their side effects effectively at home.
Participants who experienced any significant change 
(i.e., loss of  a loved one), along with the disease, showed 
poor QOL. Any major life event with the course of  
treatment could enhance stress and negative thinking in 
cancer patients. This, ultimately, affects patients, both 
physically and emotionally, which further worsens their 
well‑being. Another finding of  our study was that a majority 
of  patients were avoiding socialization which adversely 
affects their QOL, which is also substantiating by other 
studies.[36‑39] The findings also indicated that most of  the 
patients avoided going out because of  alopecia. Patients 
avoid socialization as they do not appreciate the starring 
and sympathizing looks of  strangers.[13]
Parents are among the caretakers who are extremely vital 
in obtaining favorable results of  the patients’ treatment. 
However, in this study, it was seen that those patients who 
were taken care by their parents exhibited a poor QOL. One 
of  the probable explanations for this could be that the cancer 
patients considered themselves as a burden for their families, 
which subsequently affected their QOL.[40] In the Pakistani 
culture, parents have a unique status and they are treated 
with great respect. In addition, adult children are supposed 
to look after their parents’ needs and finances in their older 
ages.[41] However, when a son or daughter is diagnosed 
with cancer, the responsibilities shift toward the parents, 
which become an additional source of  burden during their 
older age.[36] The sense of  self‑guilt and nonfulfillment of  
responsibilities toward their parents may create frustration 
in cancer patients and affecting their emotional well‑being.
Religion has a special place in an individual’s life. The 
study findings showed that a majority of  the patients found 
religious help as their priority coping mechanism, which 
is consistent with the findings of  a previous study done 
in Pakistan.[7] The regular recitation of  prayers and other 
rituals helps in coping with an illness and is considered as 
a hope for the future; hence, they develop a positive effect 
on QOL in cancer patients.[42‑43]
In Pakistan, very limited studies were conducted to 
address the QOL concerns of  adult cancer patients; 
therefore, the findings of  this study will potentially facilitate 
health policymakers and researchers for planning further 
investigations and patients care plans.
Limitations
The current study has certain limitations which need to 
be considered. Patients were recruited from single private 
health‑care setting, therefore; the findings of  the study 
Table 4: Multivariable analysis of determinants associated with 
quality of life
Characteristics β (SE [β]) 95% CI P
Female −1.51 (0.594) −2.69-−0.34 0.012
Unemployed −1.34 (0.619) −2.56-−0.11 0.032
Chemotherapy side effects (>1 week) −1.186 (0.589) −2.3-−0.020 0.046
No hospitalization 1.435 (0.548) 0.340-2.52 0.010
Parents (as caretaker) −1.620 (0.742) −3.08-−0.15 0.031
No significant change 1.56 (0.619) 0.342-2.79 0.013
No socialization −2.256 (0.523) −3.29-−1.22 <0.001
Discrimination by family/relatives −8.535 (1.984) −12.45-4.61 0.000
FACT‑G: Functional assessment of cancer therapy‑general, QOL: Quality of life, 
CI: Confidence interval, SE: Standard error
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have limited generalizability and are applicable only to 
the similar settings. In our study, the ratio of  female to 
male participants was greater which may have affected the 
findings of  this study. Keeping in mind the time limitation 
for this project, only a quantitative design was employed 
in this study. However, a mixed method approach could 
have given a better understanding of  the concept of  QOL 
in cancer patients receiving chemotherapy.
Conclusion and Recommendation
The findings of  the current study indicate poor QOL 
among adult cancer patients undergoing chemotherapy 
treatment in Karachi. Moreover, the study results identify 
emotional and physical wellbeing as severely affected 
domains of  QOL. Gender, occupational status, post 
chemotherapy side effects, lack of  socialization, and 
discrimination, and a few other factors were the significant 
determinants of  QOL. It is vital to initiate certain 
strategies for cancer patients to alleviate their physical and 
psychological sufferings and subsequently improving QOL.
This study recommends the following:
1. Strategies such as cancer support groups and 
psychological screening in the regular assessments can 
potentially help lessen emotional distress in cancer 
patients undergoing chemotherapy
2. Educate patients and their families regarding the 
management of chemotherapy treatment, this minimizes 
frequent hospitalizations and helps in obtaining better 
patients health outcomes
3. Public awareness campaigns about the disease and 
its effects need to be organized, which may help in 
eliminating the stigma and misconceptions regarding 
cancer and its treatment
4. A multidisciplinary team needs to be on board to resolve 
cancer patients’ issues without any wastage of  time.
Cancer is a major public health concern which not 
only affects patients’ physical health but also influences 
their overall QOL. Considering the severity of  this 
disease and its effects, it is necessary to identify factors 
associated with the betterment or deteriorating the 
patient’s QOL. Our study found few of  those factors 
which potentially help in making patients care plans and 
further initiate certain strategies which will contribute 
toward better QOL outcomes. Moreover, further studies 
were recommended to identify determinants that have 
not been investigated in the current study. Longitudinal 
studies are required to establish causal relationship 
between the variables.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of  interest.
References
1. American Cancer Society. Cancer facts and figures. Explore 
Research, Cancer Facts and Statistics. Available from: http://
www.cancer.org. [Last accessed on 2015 May 15].
2. World Health Organization. Cancer Fact Sheet. Available 
from: http://www.cancer.org/acs/groups/content/@research/./
acspc‑042151.pdf. [Last accessed on 2015 May 15].
3. Sankaranarayanan R, Ramadas K, Qiao YL. Managing the 
changing burden of cancer in Asia. BMC Med 2014;12:1‑17.
4. Noronha V, Tsomo U, Jamshed A, Hai M, Wattegama S, 
Baral R, et al. A fresh look at oncology facts on South central 
Asia and SAARC countries. South Asian J Cancer 2012;1:1‑4.
5. Milliman. Cancer Patients Receiving Chemotherapy: 
Opportunities for Better Management; 2010. Available 
from: http://www.us.milliman.com/uploadedFiles/insight/
research/health‑rr/cancer‑patientsreceiving‑chemotherapy.
pdf. [last accessed on 2015 Jun 04].
6. DeVita VT, Chu E. A history of cancer chemotherapy. Cancer 
Res 2008;68:8643‑53.
7. Rashid YA, Ghafoor ZA, Masood N, Mehmood T, Awan S, 
Ansar T, et al. Psychosocial impact of cancer on adult 
patients. J Pak Med Assoc 2012;62:905‑9.
8. Farrell C, Brearley SG, Pilling M, Molassiotis A. The impact 
of chemotherapy‑related nausea on patients’ nutritional 
status, psychological distress and quality of life. Support 
Care Cancer 2013;21:59‑66.
9. Younus J,  Vandenberg T, Jawaid M, Jawaid MA. 
Febrile neutropenia rates with adjuvant docetaxel and 
cyclophosphamide chemotherapy in early breast cancer: 
Discrepancy between published reports and community 
practice‑an updated analysis. Curr Oncol 2012;19:332‑4.
10. Dodd MJ, Dibble S, Miaskowski C, Paul S, Cho M, 
MacPhail L, et al. A comparison of the affective state and 
quality of life of chemotherapy patients who do and do 
not develop chemotherapy‑induced oral mucositis. J Pain 
Symptom Manage 2001;21:498‑505.
11. Karthikeyan G, Jumnani D, Prabhu R, Manoor UK, Supe SS. 
Prevalence of fatigue among cancer patients receiving 
various anticancer therapies and its impact on quality 
of life: A cross‑sectional study. Indian J Palliat Care 
2012;18:165‑75.
12. Shewbridge A, Wiseman T, Richardson A. Working while 
receiving chemotherapy: A survey of patients’ experiences 
and factors that influence these. Eur J Cancer Care (Engl) 
2012;21:117‑23.
13. Kim IR, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, et al. 
Perception, attitudes, preparedness and experience of 
chemotherapy‑induced alopecia among breast cancer 
patients: A qualitative study. Asian Pac J Cancer Prev 
2012;13:1383‑8.
14. Banning M, Hafeez H. A two‑center study of Muslim women’s 
views of breast cancer and breast health practices in Pakistan 
and the UK. J Cancer Educ 2010;25:349‑53.
15. Mkanta WN, Chumbler NR, Richardson LC, Kobb RF. 
Age‑related differences in quality of life in cancer patients: 
A pilot study of a cancer care coordination/home‑telehealth 
program. Cancer Nurs 2007;30:434‑40.
16. Pud D. Gender differences in predicting quality of life in 
cancer patients with pain. Eur J Oncol Nurs 2011;15:486‑91.
[Downloaded free from http://www.apjon.org on Saturday, May 13, 2017, IP: 111.68.111.34]
Chagani, et al.: Quality of Life in Adult Cancer Patients
Asia‑Pacific Journal of Oncology Nursing • Volume 4 • Issue 2 • April‑June 2017146
17. Admiraal JM, Reyners AK, Hoekstra‑Weebers JE. Do 
cancer and treatment type affect distress? Psychooncology 
2013;22:1766‑73.
18. Azmawati MN, Najibah E, Hatta MD, Norfazilah A. Quality 
of life by stage of cervical cancer among Malaysian patients. 
Asian Pac J Cancer Prev 2014;15:5283‑6.
19. Tan M, Karabulutlu E. Social support and hopelessness in 
Turkish patients with cancer. Cancer Nurs 2005;28:236‑40.
20. Rahmani A, Ferguson C, Jabarzadeh F, Mohammadpoorasl A, 
Moradi N, Pakpour V. Supportive care needs of Iranian cancer 
patients. Indian J Palliat Care 2014;20:224‑8.
21. Akin S, Can G, Durna Z, Aydiner A. The quality of life and 
self‑efficacy of Turkish breast cancer patients undergoing 
chemotherapy. Eur J Oncol Nurs 2008;12:449‑56.
22. Manir KS, Bhadra K, Kumar G, Manna A, Patra NB, Sarkar SK. 
Fatigue in breast cancer patients on adjuvant treatment: 
Course and prevalence. Indian J Palliat Care 2012;18:109‑16.
23. Geue K, Sender A, Schmidt R, Richter D, Hinz A, Schulte T, 
et al. Gender‑specific quality of life after cancer in young 
adulthood: A comparison with the general population. Qual 
Life Res 2014;23:1377‑86.
24. Üstündag S, Zencirci AD. Factors affecting the quality 
of life of cancer patients undergoing chemotherapy: 
A questionnaire study. Asia Pac J Oncol Nurs 2015;2:17‑25.
25. Chan A, Chiang YY, Low XH, Yap KY, Ng R. Affordability of 
cancer treatment for aging cancer patients in Singapore: An 
analysis of health, lifestyle, and financial burden. Support 
Care Cancer 2013;21:3509‑17.
26. Ma YM, Ba CF, Wang YB. Analysis of factors affecting the 
life quality of the patients with late stomach cancer. J Clin 
Nurs 2014;23:1257‑62.
27. Timmons A,  Gooberman‑Hil l  R ,  Sharp L .  The 
multidimensional nature of the financial and economic 
burden of a cancer diagnosis on patients and their 
families: Qualitative findings from a country with a mixed 
public–private healthcare system. Support Care Cancer 
2013;21:107‑17.
28. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, 
Zhong X, et al. The financial toxicity of cancer treatment: A 
pilot study assessing out‑of‑pocket expenses and the insured 
cancer patient’s experience. Oncologist 2013;18:381‑90.
29. Granda‑Cameron C, Hanlon AL, Lynch MP, Houldin A. 
Experience of newly diagnosed patients with sarcoma 
receiving chemotherapy. Oncol Nurs Forum 2011;38:160‑9.
30. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and 
their effect on the functional status of patients with cancer. 
Oncol Nurs Forum 2001;28:465‑70.
31. Maric D, Jovanovic D, Golubicic I, Dimic S, Pekmezovic T. 
Health‑related quality of life in lung cancer patients in 
Serbia: Correlation with socio‑economic and clinical 
parameters. Eur J Cancer Care (Engl) 2010;19:594‑602.
32. Phligbua W, Pongthavornkamol K, Knobf TM, Junda T, 
Viwatwongkasem C, Srimuninnimit V. Symptom clusters 
and quality of life in women with breast cancer receiving 
adjuvant chemotherapy. Int J Nurs Res 2013;17:249‑67.
33. Hjermstad MJ, Kolflaath J, Løkken AO, Hanssen SB, 
Normann AP, Aass N. Are emergency admissions in palliative 
cancer care always necessary? Results from a descriptive 
study. BMJ 2013;3:1‑8.
34. Ihbe‑Heffinger A, Paessens B, Berger K, Shlaen M, Bernard R, 
von Schilling C, et al. The impact of chemotherapy‑induced 
side effects on medical care usage and cost in German 
hospital care – An observational analysis on non‑small‑cell 
lung cancer patients. Support Care Cancer 2013;21:1665‑75.
35. Arunachalam D, Thirumoorthy A, Saraswathi Devi, T. 
Quality of life in cancer patients with disfigurement 
due to cancer and its treatments. Indian J Palliat Care 
2011;17:184‑90.
36. Banning M, Hafeez H, Faisal S, Hassan M, Zafar A. The 
impact of culture and sociological and psychological issues 
on Muslim patients with breast cancer in Pakistan. Cancer 
Nurs 2009;32:317‑24.
37. Khandelwal S, Bairy KL, Vidyasagar MS, Gonsalves J, 
Chogtu B. Quality of life in cancer patients on chemotherapy. 
World J Pharm Pharm Sci 2015;4:918‑28.
38. Nizamli F, Anoosheh M, Mohammadi E. Experiences of 
Syrian women with breast cancer regarding chemotherapy: 
A qualitative study. Nurs Health Sci 2011;13:481‑7.
39. Tang ST, Liu TW, Tsai CM, Wang CH, Chang GC, Liu LN. 
Patient awareness of prognosis, patient‑family caregiver 
congruence on the preferred place of death, and caregiving 
burden of families contribute to the quality of life for 
terminally ill cancer patients in Taiwan. Psycho oncology 
2008;17:1202‑9.
40. Khan AM, Taj R, Fatima A, Kazmi SF. Quality of life of caregivers 
and non caregivers. Ann Pak Inst Med Sci 2015;11:35‑9.
41. Grinyer A. Caring for a young adult with cancer: The 
impact on mothers’ health. Health Soc Care Community 
2006;14:311‑8.
42. Salsman JM, Yost KJ, West DW, Cella D. Spiritual well‑being 
and health‑related quality of life in colorectal cancer: A 
multi‑site examination of the role of personal meaning. 
Support Care Cancer 2011;19:757‑64.
43. Seyedrasooly A, Rahmani A, Zamanzadeh V, Aliashrafi Z, 
Nikanfar AR, Jasemi M. Association between Perception of 
prognosis and spiritual well‑being among cancer patients. 
J Caring Sci 2014;3:47‑55.
44. Lee JY, Choi S. Quality of life in gynecological cancer patients 
during chemotherapy. Korean Journal of Women Health 
Nursing 2007: 13: 4:290‑8.
45. Lobo SA, Fernandes AC, Almeida PC, Carvalho CM, 
Sawada NO. Quality of life in women with breast cancer 
undergoing chemotherapy. Acta Paulista de Enfermagem 
2014:27:6:554‑9.
[Downloaded free from http://www.apjon.org on Saturday, May 13, 2017, IP: 111.68.111.34]
